Sonim Technologies raises $1.375M via private placement of stock and warrants

DNA X, Inc.

1.1M shares of common stock and warrants for 550K shares sold for $1.375M total.
Warrants exercisable at $1.3864/share, expire May 12, 2030, subject to beneficial ownership limits.
Finder's fee of $110,000 incurred; net proceeds for working capital and general corporate purposes.
Company agreed to file registration statement by July 12, 2025 to register resale of the securities.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.